Study objective: To help people with multiple sclerosis (MS) learn skills for improving their sleep.
Eligibility criteria: To determine eligibility and enroll, visit the iSLEEPms screening form webpage. Participants must be at least 18 years old, have an MS diagnosis, have difficulty falling or staying asleep, have reliable internet access, and be willing to commit to the 12-week study period.
Study procedures: This 12-week research study will evaluate a new web-based program, iSLEEPms, which is designed to help improve sleep in people with MS. This is a randomized controlled trial, where participants will be randomly assigned to complete the four-week iSLEEPms program, or to continue their treatment as usual (TAU). iSLEEPms involves four weeks of online lessons that promote strategies and skills for improving sleep quantity and quality. Participants will be asked to complete three sets of online surveys/tests and to wear a sleep-tracking wristwatch at Week 1, Week 6, and Week 12. Each participant will have a 50% chance of being assigned to either iSLEEPms or TAU. Participants who are assigned to TAU will have the opportunity to access the iSLEEPms program after completing the study.
Study location/duration: This is a remote study with no in-person visits. Participants will be enrolled in the study for 12 weeks.
Compensation: Participants will receive up to $80 for completing each set of online questionnaires ($20 for Week 1, $30 for Week 6, and $30 for Week 12).
Study Registration: https://clinicaltrials.gov/ct2/show/NCT04147052
Principal Investigator: Abbey J. Hughes, PhD
Contact: firstname.lastname@example.org or 410-502-9234